Skip to main content

Table 2 Patient characteristics

From: Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker

Characteristics No. of Pts (N = 73) %
Sex   
   Male 48 65.8
   Female 25 34.2
Age, years   
   median 59  
   range 24–77  
Performance status   
   ECOG 0–1 60 82.2
   ECOG 2 13 17.8
Histopathologic type   
   Intestinal type 47 64.4
   Diffuse type 23 31.5
   Unknown 3 4.1
Disease status   
   Relapsed 19 26.0
   Initial stage IV 54 74.0
Metastatic site   
   Liver 30 41.1
   Peritoneum 29 39.7
   LN (distant M1 node) 23 31.5
   Others 18 24.7
  1. ECOG, eastern cooperative oncology group; LN, lymph node.